<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9548490" created="17/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9548490</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Differential induction of <term id="T1" lex="DNA-binding_activity" sem="Protein_family_or_group">DNA-binding activities</term> following <term id="T2" lex="CD19" sem="Protein_molecule">CD19</term> cross-linking in <term id="T3" lex="human_B_lineage_cell" sem="Cell_natural">human B lineage cells</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Positive_regulation"/>
<theme idref="T1"/>
<cause idref="E2"/>
<clue>Differential <clueType>induction</clueType> <linkTheme>of</linkTheme> DNA-binding activities <linkCause>following</linkCause> CD19 cross-linking in human B lineage cells.</clue>
</event>
<event KT="Other" id="E2">
<type class="Binding"/>
<theme idref="T2"/>
<clue>Differential induction of DNA-binding activities following CD19 <clueType>cross-linking</clueType> <clueLoc>in human B lineage cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T4" lex="B_cell-specific_cell_surface_molecule" sem="Protein_family_or_group">B cell-specific cell surface molecule</term> <term id="T5" lex="CD19" sem="Protein_molecule">CD19</term> is expressed at all stages of <term id="T6" lex="B_cell_development" sem="Other"><term id="A7" sem="Cell_natural">B cell</term> development</term>, including normal plasma cells, and mediates <term id="A1" sem="Other">signal transduction</term> via interaction with <term id="T7" lex="cytoplasmic_effector_protein" sem="Protein_family_or_group">cytoplasmic effector proteins</term>.</sentence>
<event KT="Fact" id="E3">
<type class="Gene_expression"/>
<theme idref="T5"/>
<clue>The <clueLoc>B cell-specific cell surface</clueLoc> molecule CD19 is <clueType>expressed</clueType> at all stages of B cell development, including normal plasma cells, and mediates signal transduction via interaction with cytoplasmic effector proteins.</clue>
</event>
<event KT="Other" id="E4">
<type class="Cell_differentiation"/>
<theme idref="A7"/>
<clue>The B cell-specific cell surface molecule CD19 is expressed at all stages of B cell <clueType>development</clueType>, including normal plasma cells, and mediates signal transduction via interaction with cytoplasmic effector proteins.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<cause idref="E6"/>
<clue>The B cell-specific cell surface molecule CD19 is expressed at all stages of B cell development, including normal plasma cells, and <clueType>mediates</clueType> signal transduction <linkCause>via</linkCause> interaction with cytoplasmic effector proteins.</clue>
</event>
<event KT="Other" id="E6">
<type class="Binding"/>
<theme idref="T5"/>
<theme idref="T7"/>
<clue>The B cell-specific cell surface molecule CD19 is expressed at all stages of B cell development, including normal plasma cells, and mediates signal transduction via <clueType>interaction</clueType> <linkTheme>with</linkTheme> cytoplasmic effector proteins.</clue>
</event>
<sentence id="S3">Cross-linking <term id="T8" lex="CD19" sem="Protein_molecule">CD19</term> on early <term id="T9" lex="human_B_lineage_cell" sem="Cell_natural">human B lineage cells</term> induces the formation of a <term id="T10" lex="CD19/Vav/phosphatidylinositol-3_kinase_complex" sem="Protein_complex"><term id="T11" lex="CD19" sem="Protein_molecule">CD19</term>/<term id="A2" sem="Protein_molecule">Vav</term>/<term id="A3" sem="Protein_molecule">phosphatidylinositol-3 kinase</term> complex</term>, <term id="T12" lex="tyrosine_phosphorylation" sem="Other"><term id="T13" lex="tyrosine" sem="Amino_acid_monomer">tyrosine</term> phosphorylation</term> of <term id="T14" lex="CD19" sem="Protein_molecule">CD19</term> and <term id="T15" lex="Vav" sem="Protein_molecule">Vav</term>, and activation of the <term id="T16" lex="Ras_pathway" sem="Other"><term id="T17" lex="Ras" sem="Protein_molecule">Ras</term> pathway</term>.</sentence>
<event KT="Other" id="E7">
<type class="Binding"/>
<theme idref="T8"/>
<clue><clueType>Cross-linking</clueType> CD19 <clueLoc>on early human B lineage cells</clueLoc> induces the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E7"/>
<clue>Cross-linking CD19 on early human B lineage cells <clueType>induces</clueType> the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="E7"/>
<clue>Cross-linking CD19 on early human B lineage cells <clueType>induces</clueType> the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.</clue>
</event>
<event KT="Fact" id="E10">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="E7"/>
<clue>Cross-linking CD19 on early human B lineage cells <clueType>induces</clueType> the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E7"/>
<clue>Cross-linking CD19 on early human B lineage cells <clueType>induces</clueType> the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.</clue>
</event>
<event KT="Other" id="E12">
<type class="Binding"/>
<theme idref="T11"/>
<theme idref="A2"/>
<theme idref="A3"/>
<clue>Cross-linking CD19 on early human B lineage cells induces the <clueType>formation</clueType> <linkTheme>of</linkTheme> a CD19/Vav/phosphatidylinositol-3 kinase <clueType>complex</clueType>, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.</clue>
<comment>CAUTION: three themes</comment></event>
<event KT="Other" id="E51">
<type class="Protein_metabolism"/>
<theme idref="T10"/>
<clue>Cross-linking CD19 on early human B lineage cells induces the <clueType>formation</clueType> <linkTheme>of</linkTheme> a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and activation of the Ras pathway.</clue>
</event>
<event KT="Other" id="E13">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T14"/>
<site idref="T13"/>
<clue>Cross-linking CD19 on early human B lineage cells induces the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> CD19 and Vav, and activation of the Ras pathway.</clue>
</event>
<event KT="Other" id="E14">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T15"/>
<site idref="T13"/>
<clue>Cross-linking CD19 on early human B lineage cells induces the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> CD19 and Vav, and activation of the Ras pathway.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T17"/>
<clue>Cross-linking CD19 on early human B lineage cells induces the formation of a CD19/Vav/phosphatidylinositol-3 kinase complex, tyrosine phosphorylation of CD19 and Vav, and <clueType>activation</clueType> <linkTheme>of</linkTheme> the Ras pathway.</clue>
</event>
<sentence id="S4">To further explore the ramifications of <term id="T18" lex="CD19" sem="Protein_molecule">CD19</term> signaling, the current study examined whether phosphorylation of <term id="T19" lex="Elk-1" sem="Protein_molecule">Elk-1</term>, activation of <term id="T20" lex="activator_protein-1" sem="Protein_molecule">activator protein-1</term> (<term id="T21" lex="AP-1" sem="Protein_molecule">AP-1</term>), or activation of nuclear factor-kappaB (<term id="T22" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>) <term id="T23" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> occurred following <term id="T24" lex="CD19_cross-linking" sem="Other"><term id="T25" lex="CD19" sem="Protein_molecule">CD19</term> cross-linking</term>.</sentence>
<event KT="Investigation" id="E16" uncertainty="doubtful">
<type class="Cell_communication"/>
<theme idref="T18"/>
<clue><clueKT>To further explore</clueKT> the ramifications of CD19 <clueType>signaling</clueType>, the current study examined whether phosphorylation of Elk-1, activation of activator protein-1 (AP-1), or activation of nuclear factor-kappaB (NF-kappaB) transcription factors occurred following CD19 cross-linking.</clue>
</event>
<event KT="Other" id="E17" uncertainty="doubtful">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T19"/>
<clue>To further explore the ramifications of CD19 signaling, the current study examined whether <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> Elk-1, activation of activator protein-1 (AP-1), or activation of nuclear factor-kappaB (NF-kappaB) transcription factors occurred following CD19 cross-linking.</clue>
</event>
<event KT="Investigation" id="E18" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="E21"/>
<clue>To further explore the ramifications of CD19 signaling, the current study <clueKT>examined</clueKT> whether phosphorylation of Elk-1, activation of activator protein-1 (AP-1), or activation of nuclear factor-kappaB (NF-kappaB) transcription factors occurred <clueType>following</clueType> CD19 cross-linking.</clue>
</event>
<event KT="Investigation" id="E19" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T21"/>
<cause idref="E21"/>
<clue>To further explore the ramifications of CD19 signaling, the current study <clueKT>examined</clueKT> whether phosphorylation of Elk-1, <clueType>activation</clueType> <linkTheme>of</linkTheme> activator protein-1 (AP-1), or activation of nuclear factor-kappaB (NF-kappaB) transcription factors occurred <linkCause>following</linkCause> CD19 cross-linking.</clue>
</event>
<event KT="Investigation" id="E20" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T22"/>
<cause idref="E21"/>
<clue>To further explore the ramifications of CD19 signaling, the current study <clueKT>examined</clueKT> whether phosphorylation of Elk-1, activation of activator protein-1 (AP-1), or <clueType>activation</clueType> <linkTheme>of</linkTheme> nuclear factor-kappaB (NF-kappaB) transcription factors occurred <linkCause>following</linkCause> CD19 cross-linking.</clue>
</event>
<event KT="Other" id="E21">
<type class="Binding"/>
<theme idref="T25"/>
<clue>To further explore the ramifications of CD19 signaling, the current study examined whether phosphorylation of Elk-1, activation of activator protein-1 (AP-1), or activation of nuclear factor-kappaB (NF-kappaB) transcription factors occurred following CD19 <clueType>cross-linking</clueType>.</clue>
</event>
<sentence id="S5">The cells used were the <term id="T26" lex="BLIN-1_pre-B_cell_line" sem="Cell_cultured">BLIN-1 pre-B cell line</term> expressing low levels of <term id="T27" lex="cell_surface_mu_heavy_chain" sem="Protein_molecule">cell surface <term id="A9" sem="Protein_molecule">mu heavy chain</term></term> associated with <term id="T28" lex="surrogate_light_chain" sem="Protein_molecule">surrogate light chain</term> and the 1E8 immature B cell line expressing <term id="T29" lex="cell_surface_mu/kappa" sem="Protein_molecule">cell surface <term id="A10" sem="Protein_molecule">mu/kappa</term></term>.</sentence>
<event Manner="Low" id="E22">
<type class="Gene_expression"/>
<theme idref="A9"/>
<clue>The cells used were the <clueLoc>BLIN-1 pre-B cell line</clueLoc> <clueType>expressing</clueType> <clueManner>low levels</clueManner> of <clueLoc>cell surface</clueLoc> mu heavy chain associated with surrogate light chain and the 1E8 immature B cell line expressing cell surface mu/kappa.</clue>
</event>
<event KT="Analysis" id="E23">
<type class="Binding"/>
<theme idref="A9"/>
<theme idref="T28"/>
<clue>The cells used were the BLIN-1 pre-B cell line expressing low levels of cell surface mu heavy chain <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> surrogate light chain and the 1E8 immature B cell line expressing cell surface mu/kappa.</clue>
</event>
<event id="E24">
<type class="Gene_expression"/>
<theme idref="A10"/>
<clue>The cells used were the BLIN-1 pre-B cell line expressing low levels of cell surface mu heavy chain associated with surrogate light chain and the <clueLoc>1E8 immature B cell line</clueLoc> <clueType>expressing</clueType> <clueLoc>cell surface</clueLoc> mu/kappa.</clue>
</event>
<sentence id="S6">Lysates from <term id="T30" lex="CD19" sem="Protein_molecule">CD19</term> cross-linked <term id="T31" lex="1E8_cell" sem="Cell_cultured">1E8 cells</term> induced robust phosphorylation of an <term id="T32" lex="Elk-1_fusion_protein" sem="Protein_molecule"><term id="T33" lex="Elk-1" sem="Protein_molecule">Elk-1</term> fusion protein</term> in vitro, whereas no phosphorylation of <term id="T34" lex="Elk-1_fusion_protein" sem="Protein_molecule"><term id="T35" lex="Elk-1" sem="Protein_molecule">Elk-1</term> fusion protein</term> occurred using lysates from <term id="T36" lex="CD19_cross-linked_BLIN-1_cell" sem="Cell_cultured"><term id="T37" lex="CD19" sem="Protein_molecule">CD19</term> cross-linked BLIN-1 cells</term>.</sentence>
<event id="E25">
<type class="Binding"/>
<theme idref="T30"/>
<clue>Lysates from CD19 <clueType>cross-linked</clueType> <clueLoc>1E8 cells</clueLoc> induced robust phosphorylation of an Elk-1 fusion protein in vitro, whereas no phosphorylation of Elk-1 fusion protein occurred using lysates from CD19 cross-linked BLIN-1 cells.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="E25"/>
<clue>Lysates from CD19 cross-linked 1E8 cells <clueType>induced</clueType> robust phosphorylation of an Elk-1 fusion protein in vitro, whereas no phosphorylation of Elk-1 fusion protein occurred using lysates from CD19 cross-linked BLIN-1 cells.</clue>
</event>
<event id="E27">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T32"/>
<clue>Lysates from CD19 cross-linked 1E8 cells induced robust <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> an Elk-1 fusion protein in vitro, whereas no phosphorylation of Elk-1 fusion protein occurred using lysates from CD19 cross-linked BLIN-1 cells.</clue>
</event>
<event id="E28">
<type class="Binding"/>
<theme idref="T37"/>
<clue>Lysates from CD19 cross-linked 1E8 cells induced robust phosphorylation of an Elk-1 fusion protein in vitro, whereas no phosphorylation of Elk-1 fusion protein occurred using lysates from CD19 <clueType>cross-linked</clueType> <clueLoc>BLIN-1 cells</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E29">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="E28"/>
<clue>Lysates from CD19 cross-linked 1E8 cells induced robust phosphorylation of an Elk-1 fusion protein in vitro, whereas <cluePolarity>no</cluePolarity> phosphorylation of Elk-1 fusion protein <clueType>occurred</clueType> <linkCause>using</linkCause> lysates from CD19 cross-linked BLIN-1 cells.</clue>
</event>
<event KT="Other" id="E30">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T34"/>
<clue>Lysates from CD19 cross-linked 1E8 cells induced robust phosphorylation of an Elk-1 fusion protein in vitro, whereas no <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> Elk-1 fusion protein occurred using lysates from CD19 cross-linked BLIN-1 cells.</clue>
</event>
<sentence id="S7">An <term id="T38" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assay</term> employing <term id="T39" lex="AP-1" sem="Protein_molecule">AP-1</term> and <term id="T40" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> consensus <term id="T41" lex="oligonucleotide" sem="Polynucleotide">oligonucleotides</term> was used to demonstrate that <term id="T42" lex="AP-1_-binding_activity" sem="Other"><term id="T43" lex="AP-1" sem="Protein_molecule">AP-1</term> -binding activity</term> increased, while constitutive <term id="T44" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>-binding activity was not enhanced, following 2 h of <term id="T45" lex="CD19" sem="Protein_molecule">CD19</term> cross-linking in <term id="T46" lex="1E8_cell" sem="Cell_cultured">1E8 cells</term>.</sentence>
<event KT="Other" id="E31">
<type class="Binding"/>
<theme idref="T39"/>
<clue>An <clueExperiment>electrophoretic mobility shift assay</clueExperiment> employing AP-1 and NF-kappaB consensus oligonucleotides was used to demonstrate that AP-1 -<clueType>binding activity</clueType> increased, while constitutive NF-kappaB-binding activity was not enhanced, following 2 h of CD19 cross-linking in 1E8 cells.</clue>
</event>
<event KT="Analysis" id="E32">
<type class="Positive_regulation"/>
<theme idref="T43"/>
<cause idref="E35"/>
<clue>An electrophoretic mobility shift assay employing AP-1 and NF-kappaB consensus oligonucleotides was used to <clueKT>demonstrate</clueKT> that AP-1 -binding activity <clueType>increased</clueType>, while constitutive NF-kappaB-binding activity was not enhanced, <linkCause>following</linkCause> <clueTime>2 h</clueTime> of CD19 cross-linking <clueLoc>in 1E8 cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E33">
<type class="Binding"/>
<theme idref="T44"/>
<clue>An <clueExperiment>electrophoretic mobility shift assay</clueExperiment> employing AP-1 and NF-kappaB consensus oligonucleotides was used to demonstrate that AP-1 -binding activity increased, while constitutive NF-kappaB-<clueType>binding activity</clueType> was not enhanced, following 2 h of CD19 cross-linking in 1E8 cells.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E34">
<type class="Positive_regulation"/>
<theme idref="E33"/>
<cause idref="E35"/>
<clue>An electrophoretic mobility shift assay employing AP-1 and NF-kappaB consensus oligonucleotides was used to <clueKT>demonstrate</clueKT> that AP-1 -binding activity increased, while constitutive NF-kappaB-binding activity was <cluePolarity>not</cluePolarity> <clueType>enhanced</clueType>, <linkCause>following</linkCause> <clueTime>2 h</clueTime> of CD19 cross-linking <clueLoc>in 1E8 cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E35">
<type class="Binding"/>
<theme idref="T45"/>
<clue>An electrophoretic mobility shift assay employing AP-1 and NF-kappaB consensus oligonucleotides was used to demonstrate that AP-1 -binding activity increased, while constitutive NF-kappaB-binding activity was not enhanced, following 2 h of CD19 <clueType>cross-linking</clueType> in 1E8 cells.</clue>
</event>
<sentence id="S8"><term id="T47" lex="supershift_experiment" sem="Other">Supershift experiments</term> revealed that <term id="T48" lex="JunD" sem="Protein_molecule">JunD</term> and <term id="T49" lex="c-Fos_protein" sem="Protein_molecule"><term id="A4" sem="Protein_molecule">c-Fos</term> proteins</term> mediated <term id="A5" sem="Protein_molecule">anti-<term id="T50" lex="CD19" sem="Protein_molecule">CD19</term></term> induced <term id="T51" lex="AP-1-binding_activity" sem="Other"><term id="T52" lex="AP-1" sem="Protein_molecule">AP-1</term>-binding activity</term> in <term id="T53" lex="1E8_cell" sem="Cell_cultured">1E8 cells</term>.</sentence>
<event KT="Analysis" id="E36">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="T48"/>
<clue><clueExperiment>Supershift experiments</clueExperiment> <clueKT>revealed</clueKT> that JunD and c-Fos proteins <clueType>mediated</clueType> anti-CD19 induced AP-1-binding activity in 1E8 cells.</clue>
</event>
<event KT="Analysis" id="E37">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="A4"/>
<clue><clueExperiment>Supershift experiments</clueExperiment> <clueKT>revealed</clueKT> that JunD and c-Fos proteins <clueType>mediated</clueType> anti-CD19 induced AP-1-binding activity in 1E8 cells.</clue>
</event>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="A5"/>
<clue>Supershift experiments revealed that JunD and c-Fos proteins mediated anti-CD19 <clueType>induced</clueType> AP-1-binding activity <clueLoc>in 1E8 cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E39">
<type class="Binding"/>
<theme idref="T52"/>
<clue>Supershift experiments revealed that JunD and c-Fos proteins mediated anti-CD19 induced AP-1-<clueType>binding activity</clueType> in 1E8 cells.</clue>
</event>
<sentence id="S9">In contrast, <term id="T54" lex="CD19" sem="Protein_molecule">CD19</term> cross-linking in <term id="T55" lex="BLIN-1_cell" sem="Cell_cultured">BLIN-1 cells</term> resulted in the induction of <term id="T56" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>, but had no apparent effect on <term id="T57" lex="AP-1-binding_activity" sem="Other"><term id="T58" lex="AP-1" sem="Protein_molecule">AP-1</term>-binding activity</term>.</sentence>
<event id="E40">
<type class="Binding"/>
<theme idref="T54"/>
<clue>In contrast, CD19 <clueType>cross-linking</clueType> <clueLoc>in BLIN-1 cells</clueLoc> resulted in the induction of NF-kappaB, but had no apparent effect on AP-1-binding activity.</clue>
</event>
<event id="E41">
<type class="Positive_regulation"/>
<theme idref="T56"/>
<cause idref="E40"/>
<clue>In contrast, CD19 cross-linking in BLIN-1 cells <clueType>resulted in the induction</clueType> <linkTheme>of</linkTheme> NF-kappaB, but had no apparent effect on AP-1-binding activity.</clue>
</event>
<event KT="Other" id="E42">
<type class="Binding"/>
<theme idref="T58"/>
<clue>In contrast, CD19 cross-linking in BLIN-1 cells resulted in the induction of NF-kappaB, but had no apparent effect on AP-1-<clueType>binding activity</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E43">
<type class="Regulation"/>
<theme idref="E42"/>
<cause idref="E40"/>
<clue>In contrast, CD19 cross-linking in BLIN-1 cells resulted in the induction of NF-kappaB, but had <cluePolarity>no</cluePolarity> <clueKT><clueCL>apparent</clueCL></clueKT> <clueType>effect</clueType> <linkTheme>on</linkTheme> AP-1-binding activity.</clue>
</event>
<sentence id="S10">These data suggest that <term id="T60" lex="CD19" sem="Protein_molecule">CD19</term>-mediated <term id="A6" sem="Other">signal transduction</term> activates different <term id="T61" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> at juxtaposed stages of <term id="T62" lex="B_cell_development" sem="Other"><term id="A8" sem="Cell_natural">B cell</term> development</term> that may culminate in the activation or suppression of distinct sets of <term id="T63" lex="gene" sem="DNA_domain_or_region">genes</term>.</sentence>
<event KT="Other" id="E44">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="T60"/>
<clue>These data suggest that CD19-<clueType>mediated</clueType> signal transduction activates different transcription factors at juxtaposed stages of B cell development that may culminate in the activation or suppression of distinct sets of genes.</clue>
</event>
<event CL="L2" KT="Analysis" id="E45" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T61"/>
<cause idref="E44"/>
<clue>These data <clueKT><clueCL>suggest</clueCL></clueKT> that CD19-mediated signal transduction <clueType>activates</clueType> different transcription factors at juxtaposed stages of B cell development that may culminate in the activation or suppression of distinct sets of genes.</clue>
</event>
<event KT="Other" id="E46">
<type class="Cell_differentiation"/>
<theme idref="A8"/>
<clue>These data suggest that CD19-mediated signal transduction activates different transcription factors at juxtaposed stages of B cell <clueType>development</clueType> that may culminate in the activation or suppression of distinct sets of genes.</clue>
</event>
<event CL="L1" KT="Analysis" id="E47" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E49"/>
<cause idref="E45"/>
<clue>These data suggest that CD19-mediated signal transduction activates different transcription factors at juxtaposed stages of B cell development that <clueKT><clueCL>may</clueCL></clueKT> <clueType>culminate</clueType> <linkTheme>in</linkTheme> the activation or suppression of distinct sets of genes.</clue>
</event>
<event CL="L1" KT="Analysis" id="E48" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E50"/>
<cause idref="E45"/>
<clue>These data suggest that CD19-mediated signal transduction activates different transcription factors at juxtaposed stages of B cell development that <clueKT><clueCL>may</clueCL></clueKT> <clueType>culminate</clueType> <linkTheme>in</linkTheme> the activation or suppression of distinct sets of genes.</clue>
</event>
<event KT="Other" id="E49">
<type class="Positive_regulation"/>
<theme idref="T63"/>
<clue>These data suggest that CD19-mediated signal transduction activates different transcription factors at juxtaposed stages of B cell development that may culminate in the <clueType>activation</clueType> or suppression <linkTheme>of</linkTheme> distinct sets of genes.</clue>
</event>
<event KT="Other" id="E50">
<type class="Negative_regulation"/>
<theme idref="T63"/>
<clue>These data suggest that CD19-mediated signal transduction activates different transcription factors at juxtaposed stages of B cell development that may culminate in the activation or <clueType>suppression</clueType> <linkTheme>of</linkTheme> distinct sets of genes.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
